US 2020/0002379 A9Published application

Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease

AssigneeForschungszentrum Juelich GmbH

InventorDieter WILLBOLD

Life of this patent

Estimating the term…

Abstract

Amyloid beta-binding peptides and the use thereof for the treatment and the diagnosis of Alzheimer's disease.

Claims23

Dependent claims

A peptide, comprising at least one amino acid sequence which binds to amyloid beta species and in which the negative charge of the carboxyl group typically present at the free C-terminus was removed by modification, whereby no charge or a positive charge is present there.

Dependencies are inferred from the claim text.

Facts

Application: 15/022,749Filed 23 Sep 2014
Priority: DE 10 2013 016 002.226 Sep 2013
Published: 2 Jan 2020
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

C07K 7/08
Linear peptides containing only normal peptide links: having 12 to 20 amino acids
A61K 38/10
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: peptides having 12 to 20 amino acids
A61K 38/12
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: cyclic peptides , e.g. bacitracins; Polymyxins; Gramicidins…
A61K 38/16
Medicinal preparations containing peptides: peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Family

Application14/388,869Continuation in part · filed 29 Sep 2014
Application15/022,749Continuation in part
US 10,995,118 B2Related patent
US 2015/0119336 A1Published application
US 2016/0297852 A1Published application
US 9,464,118 B2Related patent
US 2020/0002379 A9This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Facts

Application

15/022,749Filed 23 Sep 2014

Priority

DE 10 2013 016 002.226 Sep 2013

Published

2 Jan 2020

Term ends

Not estimatedThe source records don’t support an estimate.

Classification13 codes

C07K 7/08
Linear peptides containing only normal peptide links: having 12 to 20 amino acids
A61K 38/10
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: peptides having 12 to 20 amino acids
A61K 38/12
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: cyclic peptides , e.g. bacitracins; Polymyxins; Gramicidins…
A61K 38/16
Medicinal preparations containing peptides: peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Family

Application14/388,869Continuation in part · filed 29 Sep 2014

Application15/022,749Continuation in part

US 10,995,118 B2Related patent

US 2015/0119336 A1Published application

US 2016/0297852 A1Published application

US 9,464,118 B2Related patent

US 2020/0002379 A9This patent

From the US filing history. Foreign family members aren’t listed.